As rehabilitation science continues to evolve, clinicians are increasingly looking beyond single-modality treatment protocols. The growing interest in shockwave and ultrasound therapy as a combined approach reflects a broader shift toward multimodal care - using complementary technologies in sequence or together to address the complex, layered nature of musculoskeletal injury and chronic pain.
This article explores how each modality works, why their combination can be clinically meaningful, and how rehabilitation professionals can implement a practical, evidence-informed workflow when using both therapies in practice.
Understanding the Two Modalities
What Is Shockwave Therapy?
Extracorporeal Shockwave Therapy (ESWT) delivers high-energy acoustic waves to targeted tissue through a handheld applicator. These pressure waves create a rapid mechanical stimulus within the tissue, triggering a series of biological responses.
At the cellular level, shockwave therapy is thought to stimulate neovascularisation (the formation of new blood vessels), disrupt calcific deposits, desensitise local nerve endings, and promote the release of growth factors that initiate tissue repair. It is particularly well regarded for its ability to address chronic, treatment-resistant conditions where conventional physiotherapy has plateaued.
There are two primary delivery types: radial shockwave, which disperses energy over a broader surface area and is suited to larger muscle groups, and focused shockwave, which concentrates energy at a precise depth for deeper tissue pathology.
What Is Therapeutic Ultrasound?
Therapeutic ultrasound uses high-frequency sound waves - typically in the range of 1 to 3 MHz - to deliver energy into soft tissue. Unlike diagnostic ultrasound, which is used purely for imaging, therapeutic ultrasound is designed to produce physiological effects within the tissue itself.
It operates through two primary mechanisms. Thermal effects occur when continuous ultrasound raises local tissue temperature, improving extensibility, increasing metabolic activity, and supporting circulation. Non-thermal (mechanical) effects, produced through pulsed ultrasound, include acoustic cavitation and microstreaming, which are thought to influence cell membrane permeability, protein synthesis, and the inflammatory cascade.
Therapeutic ultrasound is widely used in physiotherapy for soft tissue injuries, scar tissue management, joint conditions, and as a preparatory tool before manual therapy or exercise.
Ultrasound vs Shockwave Therapy: Understanding the Difference
A question commonly raised in clinical settings is: can ultrasound be used with shockwave therapy, and is there any overlap?
While both modalities use acoustic energy, they operate at fundamentally different frequencies, intensities, and tissue depths - and produce distinct biological effects. Shockwave therapy operates at much lower frequencies with significantly higher energy output, designed to create a mechanical shock response in the tissue. Therapeutic ultrasound operates at higher frequencies with lower energy, producing subtler thermal and cellular-level effects.
Rather than competing, the two modalities are in many ways complementary. Ultrasound can prepare tissue for deeper intervention, while shockwave therapy addresses pathological changes that ultrasound alone may not reach effectively. Understanding this distinction is the foundation for building effective combination protocols.
Why Combining Shockwave and Ultrasound Therapy Can Improve Outcomes
The benefits of combining shockwave and ultrasound therapy stem from the fact that most musculoskeletal conditions are not one-dimensional. A chronic tendinopathy, for example, may involve degenerative tissue changes, local inflammation, restricted circulation, pain sensitisation, and functional restriction - all at once.
Addressing only one of these layers with a single modality inevitably leaves other aspects of the pathology under-treated. Combination therapy allows clinicians to:
Prepare the tissue using therapeutic ultrasound to improve perfusion, reduce tissue stiffness, and support the inflammatory environment before shockwave application
Target deeper pathological changes with shockwave, stimulating cellular repair mechanisms and disrupting calcific or fibrotic tissue
Support post-treatment recovery with ultrasound in subsequent sessions to encourage tissue remodelling and manage any residual inflammation
This layered approach aligns with the principle of treating the whole tissue environment, not just the primary symptom.
Clinical Benefits of Combination Therapy
When implemented appropriately, combination therapy shockwave ultrasound protocols offer several potential clinical advantages:
Enhanced tissue response: Sequential application of the two modalities may amplify the biological signals associated with tissue repair, potentially supporting faster and more complete recovery compared to either modality used in isolation.
Broader pain management: Ultrasound's thermal effects and shockwave's neuromodulatory mechanisms address pain through different pathways, offering more comprehensive analgesia for patients with both nociceptive and sensitised pain.
Improved treatment of chronic conditions: Chronic musculoskeletal conditions are often characterised by poor local circulation and stalled repair processes. Combining the two modalities addresses both circulatory preparation and deeper tissue stimulation simultaneously.
Reduced session fatigue for patients: By achieving more within each treatment visit through a structured protocol, clinicians can often reduce overall treatment duration while maintaining or improving outcomes.
Conditions That May Benefit From the Combination Approach
The following musculoskeletal conditions are among those where combination therapy protocols are most commonly explored in clinical practice:
Tendinopathy
Conditions such as Achilles tendinopathy, patellar tendinopathy, and rotator cuff tendinopathy involve structural changes to tendon tissue that can be addressed at multiple levels - circulatory, cellular, and mechanical - making them strong candidates for a combined approach.
Plantar Fasciitis
One of the most common indications for shockwave therapy, plantar fasciitis often also involves localised soft tissue restriction and inflammation that responds well to the preparatory application of therapeutic ultrasound.
Muscle Injuries and Delayed-Onset Soreness
In cases of Grade I or Grade II muscle strains, therapeutic ultrasound can support the early inflammatory phase of healing, while shockwave may be introduced in later stages to address any fibrotic changes or persistent pain.
Calcific Tendinitis
Shockwave therapy is well established for disrupting calcium deposits, while ultrasound therapy may support the reabsorption process and surrounding tissue recovery.
Scar Tissue and Adhesions
Post-surgical or post-traumatic soft tissue adhesions can be approached with ultrasound to improve tissue mobility, followed by shockwave to address deeper structural restrictions.
Typical Treatment Workflow Using Both Therapies
A practical combination therapy session might follow this general structure, though protocols should always be individualised based on clinical presentation:
Assessment and preparation: Confirm treatment indications, contraindications, and tissue status. Explain the session plan to the patient.
Therapeutic ultrasound application (5–10 minutes): Apply pulsed or continuous ultrasound to the target area depending on the stage of the condition. This step prepares tissue by improving circulation and reducing local stiffness.
Shockwave therapy (5–10 minutes): Apply radial or focused shockwave to the primary pathological area. With the tissue already prepared by ultrasound, this step may be better tolerated and more effective.
Post-treatment care: Advise on activity modification, expected post-treatment response, and home care. Document settings and patient response for continuity.
Subsequent sessions may adjust the sequencing or intensity based on patient feedback and clinical progress.
Advantages for Clinics Using Integrated Combination Therapy Devices
As demand for multimodal treatment grows, a number of manufacturers now offer integrated systems that combine both shockwave and ultrasound therapy within a single device platform. For clinics considering this approach, the workflow implications are significant.
Rather than managing two separate units, cables, and applicator sets, an integrated device allows clinicians to transition seamlessly between modalities within a single session. This reduces setup time, simplifies documentation of settings, and improves the overall patient experience by minimising interruptions.
From a clinical governance perspective, integrated systems also make it easier to maintain consistent protocols across different practitioners within the same clinic, supporting reproducibility and treatment quality.
For clinics operating across multiple treatment rooms or mobile settings, the reduced equipment footprint of an all-in-one device offers practical and economic advantages without compromising therapeutic capability.
Safety Considerations
Combination therapy protocols carry the same contraindication profiles as each individual modality. Clinicians should be familiar with the following:
Shared contraindications for both modalities include: active malignancy in the treatment area, pregnancy (particularly over the abdomen or lower back), implanted electronic devices such as cardiac pacemakers, acute infections, and areas of impaired sensation.
Shockwave-specific cautions: Avoid application over growth plates in paediatric patients, areas of coagulopathy or active bleeding, and directly over nerve trunks or the spine without appropriate training.
Ultrasound-specific cautions: Avoid thermal-mode application over areas with metal implants, ischaemic tissue, or directly over the eyes or reproductive organs.
When introducing combination protocols, it is advisable to begin conservatively with established single-modality experience before integrating both into a single session. Appropriate training and adherence to manufacturer guidelines for any device used are essential.
Frequently Asked Questions
Can ultrasound be used with shockwave therapy in the same session? Yes, in most cases the two modalities can be used within the same session. Typically, ultrasound is applied first as a preparatory step, followed by shockwave. Patient presentation and contraindication status should always be assessed first.
Which conditions respond best to combination therapy? Chronic tendinopathies, plantar fasciitis, calcific tendinitis, and soft tissue adhesions are among the conditions most commonly treated with combination protocols in clinical practice.
Is one therapy better than the other? Ultrasound and shockwave therapy serve different clinical purposes and are not directly interchangeable. The choice depends on the condition, its stage, and the treatment goals. Many clinicians find the greatest value in using them together rather than choosing between them.
How many sessions are typically needed? This varies considerably by condition and patient response. Many shockwave protocols involve three to six sessions. Ultrasound may be used more frequently across the same treatment period. A qualified physiotherapist can advise based on individual assessment.
Are there any additional risks when combining both therapies? When both modalities are applied within their respective safe parameters and contraindication guidelines are followed, combining them does not generally introduce additional risks. Clinician training and appropriate patient selection remain the most important safety factors.
Conclusion
The evidence base and clinical rationale for combining shockwave and ultrasound therapy in rehabilitation continues to grow. For physiotherapists, sports medicine clinicians, and rehabilitation professionals looking to optimise outcomes for patients with complex or chronic musculoskeletal presentations, a thoughtfully designed combination protocol offers a meaningful step forward from single-modality care.
Neither modality needs to replace the other. Instead, they can be understood as complementary tools that - when applied with clinical precision and appropriate patient selection - address different dimensions of the same pathological picture. Clinicians who take the time to understand both technologies, invest in proper training, and explore the practical benefits of integrated device platforms will be well positioned to offer a higher standard of care.
If you have not yet explored the clinical potential of combination therapy, now is a compelling time to do so.